Uromigos Live 2023: Dr. Anis Hamid on Where PSMAfore Sits In mCRPC Sequencing

At The Uromigos Live & Unplugged event, Anis Hamid, MBBS, Memorial Sloan Kettering Cancer Center, provides his feedback on the PSMAfore study, how it impacts treatment sequencing in mCRPC, and how future trials can strengthen the control arm competing against Lu-177 PSMA-617.

As for his favorite part of the event, Dr. Hamid expresses his gratitude toward being able to speak with senior faculty and add to the “collection of minds.”